Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis ...Middle East

PR Newswire - News

OX640 is a nasal rescue medication with powder-based epinephrine for the treatment of allergic reactions (incl. anaphylaxis) and is based on the proprietary AmorphOX® technology. The clinical study, OX640-002, evaluated both pharmacokinetic and pharmacodynamic effects of OX640 in subjects...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis )

    Apple Storegoogle play

    Also on site :